Everett E. Vokes

University of Chicago

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Christine Bestvina

Assistant Professor

University of Chicago Medicine

UNITED STATES

View details

Marina Garassino

Università degli Studi di Torino

ITALY

View details

Jonathan W. Goldman

Associate Professor

UCLA

UNITED STATES

View details

David S. Hong

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Laura Chow

Professor, Associate Director Clinical Research

University of Texas at Austin

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Everett E. Vokes

Research Interests

Explore related searches

Contact this professor

Articles (11)

Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein–Expressing Non–Small-Cell Lung Cancer

Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal

Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal

A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck

2022 Presidential Address: Advancing Equitable Cancer Care Through Innovation

A Global Approach to Cancer Equity in the Hispanic/Latinx Population

Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non–Small Cell Lung Carcinoma

Is This the Dawn of Precision Oncology in Head and Neck Cancer?

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

Adjuvant treatment for high‐risk salivary gland malignancies and prognostic stratification based on a 20‐year single institution experience

A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Collaborators (5)

Christine Bestvina

Marina Garassino

Jonathan W. Goldman

David S. Hong

Laura Chow

Make your next move.